About Vibro Pharma Private Limited
Data last updated:
Vibro Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 01 April 1960 and has been in existence for over 66 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1960PTC011626. Its GSTIN is 27AAACV1266A1ZR (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rajendra Kantilal Shah (Managing Director) and Vishal Rajendra Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lalwani Industrial Estate14 G D Ambekar Road Wadala, Mumbai, Maharashtra, India – 400031.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.45 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹3.12 Cr (net margin 13.3%) and EBITDA of ₹4.36 Cr (EBITDA margin 18.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 11% over five years.
As per MCA filings, the company has satisfied charges of ₹14 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vibropharma.com.
Company details
Contact details
Vibro Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is vibropharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressLalwani Industrial Estate14 G D Ambekar Road Wadala, Mumbai, Maharashtra, India – 400031
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Vibro Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vibro Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vibro Pharma Private Limited, buy the company report.
Financials of Vibro Pharma Private Limited
FY 2025 filings availableVibro Pharma Private Limited reported revenue of ₹23.45 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 4% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.36 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.12 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.6% | ||||
| Net Profit Margin | 13.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vibro Pharma Private Limited, buy the company report.
Board of directors of Vibro Pharma Private Limited
Vibro Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Rajendra Shah Also directs: Crescent Labs Private Limited, Unisol Estate Private Limited | Whole-Time Director | 01 Apr 1996 | 30 Years 7 Months | Current |
| Rita Rajendra Shah | Director | 16 May 1994 | 32 Years 5 Months | Current |
| Rajendra Kantilal Shah Also directs: Crescent Labs Private Limited, Unisol Estate Private Limited | Managing Director | 17 Aug 1966 | 60 Years 2 Months | Current |
Peer comparison
Vibro Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Akron Parentarals Private Limited | ₹25.9 Cr (FY 2025) | 26.0% | Muppalla, Andhra Pradesh, India | |||
| Bushal Chemi-Pharma Private Limited | ₹25.58 Cr (FY 2025) | 3.0% | Badlapur, Maharashtra, India | |||
| Indian Genomix Private Limited | ₹23.72 Cr (FY 2025) | 6.0% | Hyderabad, Telangana, India | |||
| Gentle Bio-Sciences Private Limited | ₹23.7 Cr (FY 2024) | -12.0% | Hyderabad, Telangana, India | |||
| Vibro Pharma Private Limitedthis company | ₹23.45 Cr (FY 2025) | ₹3.12 Cr | 13.3% | 4.0% | Mumbai, Maharashtra, India | |
| Konar Organics Limited | ₹23.36 Cr (FY 2025) | -3.0% | Hyderabad, Telangana, India | |||
| Interface Pharmaceuticals Pvt Ltd | ₹22.92 Cr (FY 2025) | 13.0% | New Delhi, Delhi, India | |||
| Vvaan Lifesciences Private Limited | ₹21.83 Cr (FY 2025) | 11.0% | Thane, Maharashtra, India |
To see the full peer comparison of Vibro Pharma Private Limited, buy the company report.
Auditor
Vibro Pharma Private Limited is audited by Yatin C. Shah & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Yatin C. Shah & Associates | FY 2023 | 129534W |
Shareholding
The shareholding of Vibro Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vibro Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jun 1999 | 90163872 | Union Bank of India | ₹2 Lakh | Satisfied | |
| 05 Mar 1999 | 90163835 | Union Bank of India | ₹4 Lakh | Satisfied | |
| 05 Mar 1999 | 90166614 | Union Bank of India | ₹2.75 Lakh | Satisfied | |
| 04 Mar 1987 | 90162033 | Union Bank of India | ₹2.75 Lakh | Satisfied | |
| 10 Jan 1980 | 90161547 | Union Bak of Indiaa | ₹50,000 | Satisfied |
To see the full charge records of Vibro Pharma Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
No court or tribunal cases involving Vibro Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vibro Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vibro Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACV1266A1ZR | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vibro Pharma Private Limited, buy the company report.
Recent activity
Vibro Pharma Private Limited has 3 board changes on record since 1966: 3 appointments. The latest: Vishal Rajendra Shah was appointed as Whole-Time Director on 01 Apr 1996.
13 earlier events are in the company report.
Frequently asked questions
Vibro Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 01 April 1960 (66+ years old) and is registered under CIN U99999MH1960PTC011626.
Vibro Pharma has 3 current directors:
- Rajendra Kantilal Shah - Managing Director
- Vishal Rajendra Shah - Whole-Time Director
- Rita Rajendra Shah - Director
The latest financial statements of Vibro Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vibro Pharma is 27AAACV1266A1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vibro Pharma is U99999MH1960PTC011626. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vibro Pharma was incorporated on 01 April 1960, making it 66+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vibro Pharma by revenue are Akron Parentarals Private Limited, Bushal Chemi-Pharma Private Limited, Indian Genomix Private Limited, Gentle Bio-Sciences Private Limited, Konar Organics Limited and 2 more, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vishal Rajendra Shah was appointed as Whole-Time Director on 01 Apr 1996. Rita Rajendra Shah was appointed as Director on 16 May 1994. Rajendra Kantilal Shah was appointed as Managing Director on 17 Aug 1966.
Vibro Pharma can be reached through the website vibropharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Vibro Pharma is at Lalwani Industrial Estate14 G D Ambekar Road Wadala, Mumbai, Maharashtra, India – 400031.
Vibro Pharma operates in the pharma industry, in the animal pharmaceuticals and healthcare segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
